Hepatitis A Antibodies

Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Also Known As:
Anti-HAV; Anti HAV; Antibodies, Hepatitis A; Hepatitis A Virus Antibodies
Networked: 566 relevant articles (12 outcomes, 56 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Poovorawan, Yong: 5 articles (10/2013 - 03/2002)
2. Gaspar, A M C: 4 articles (05/2008 - 08/2003)
3. de Paula, V S: 4 articles (05/2008 - 01/2001)
4. Theamboonlers, Apiradee: 3 articles (10/2013 - 01/2005)
5. Souto, Francisco José Dutra: 3 articles (08/2012 - 03/2002)
6. Gaspar, Ana Maria Coimbra: 3 articles (08/2012 - 03/2002)
7. Smetana, J: 3 articles (09/2011 - 08/2006)
8. Arankalle, V A: 3 articles (08/2009 - 06/2002)
9. Gaspar, Ana M C: 3 articles (02/2009 - 01/2002)
10. Zhang, Yong: 3 articles (09/2007 - 05/2002)

Related Diseases

1. Hepatitis A (Hepatitis, Infectious)
2. Infection
09/01/2015 - "BackgroundRural populations present an elevated risk of exposure to hepatitis A virus.ObjectiveThe objective of this study was to estimate the prevalence and risk factors associated with hepatitis A virus infection among residents of rural settlement projects of southwest Goiás, Central Brazil.MethodsA total of 466 residents were interviewed and tested for the detection of anti- hepatitis A virus antibodies by ELISA.ResultsThe global prevalence of anti- hepatitis A virus was 82.2%. "
12/01/2004 - "Lifelong immunity is conferred by infection or vaccination, so anti-HAV seroprevalence studies can be used to indicate which populations are susceptible to infection. "
06/01/2002 - "Our study, comparing with previous reports from other parts in Thailand, indicates a steady decline of anti-HAV prevalence among schoolchildren in Chiang Mai area, and discussed a possibility of an outbreak of HAV infection among urban schoolchildren."
01/01/1992 - "Studies of active and passive immunoprophylaxis were carried out in chimpanzees to determine whether a candidate hepatitis A virus (HAV) vaccine could stimulate antibody to HAV (anti-HAV) that was qualitatively similar to anti-HAV stimulated by natural infection. "
01/01/1983 - "Our studies to date have focused most heavily on the development of a live, attenuated HAV vaccine, although we have also made a prototype killed HAV vaccine form infected marmoset liver which induced anti-HAV and solid immunity to infection in marmosets. "
3. Hepatitis
4. Hepatitis B
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Immunoglobulin M (IgM)
2. Antibodies
3. Immunoglobulin G (IgG)
4. Hepatitis B Vaccines (Hepatitis B Vaccine)
5. Hepatitis B Surface Antigens (HBsAg)
6. Antigens
7. Immunoglobulins (Immunoglobulin)
8. Antigen-Antibody Complex (Immune Complex)
9. RNA (Ribonucleic Acid)
10. Hepatitis A Vaccines (Hepatitis A Vaccine)

Related Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Renal Dialysis (Hemodialysis)
3. Liver Transplantation
4. Day Care (Partial Hospitalization)
5. Tattooing